115 related articles for article (PubMed ID: 38040915)
1. Correction: Clinical findings and a DNA methylation signature in kindreds with alterations in ZNF711.
Wang J; Foroutan A; Richardson E; Skinner SA; Reilly J; Kerkhof J; Curry CJ; Tarpey PS; Robertson SP; Maystadt I; Keren B; Dixon JW; Skinner C; Stapleton R; Ruaud L; Gumus E; Lakeman P; Alders M; Tedder ML; Schwartz CE; Friez MJ; Sadikovic B; Stevenson RE
Eur J Hum Genet; 2023 Dec; ():. PubMed ID: 38040915
[No Abstract] [Full Text] [Related]
2. Clinical findings and a DNA methylation signature in kindreds with alterations in ZNF711.
Wang J; Foroutan A; Richardson E; Skinner SA; Reilly J; Kerkhof J; Curry CJ; Tarpey PS; Robertson SP; Maystadt I; Keren B; Dixon JW; Skinner C; Stapleton R; Ruaud L; Gumus E; Lakeman P; Alders M; Tedder ML; Schwartz CE; Friez MJ; Sadikovic B; Stevenson RE
Eur J Hum Genet; 2022 Apr; 30(4):420-427. PubMed ID: 34992252
[TBL] [Abstract][Full Text] [Related]
3. ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression.
Wu G; Peng H; Tang M; Yang M; Wang J; Hu Y; Li Z; Li J; Li Z; Song L
EBioMedicine; 2021 Sep; 71():103558. PubMed ID: 34521054
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of ZNF711 in Human Breast Cancer.
Li X; Tian L; Zhang L; Xu B; Zhang Y; Li Q
Onco Targets Ther; 2020; 13():6593-6601. PubMed ID: 32753895
[TBL] [Abstract][Full Text] [Related]
5. Mutations in two large pedigrees highlight the role of ZNF711 in X-linked intellectual disability.
van der Werf IM; Van Dijck A; Reyniers E; Helsmoortel C; Kumar AA; Kalscheuer VM; de Brouwer AP; Kleefstra T; van Bokhoven H; Mortier G; Janssens S; Vandeweyer G; Kooy RF
Gene; 2017 Mar; 605():92-98. PubMed ID: 27993705
[TBL] [Abstract][Full Text] [Related]
6. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation.
Kleine-Kohlbrecher D; Christensen J; Vandamme J; Abarrategui I; Bak M; Tommerup N; Shi X; Gozani O; Rappsilber J; Salcini AE; Helin K
Mol Cell; 2010 Apr; 38(2):165-78. PubMed ID: 20346720
[TBL] [Abstract][Full Text] [Related]
7. A DNA methylation signature to improve survival prediction of gastric cancer.
Peng Y; Wu Q; Wang L; Wang H; Yin F
Clin Epigenetics; 2020 Jan; 12(1):15. PubMed ID: 31959204
[TBL] [Abstract][Full Text] [Related]
8. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
[TBL] [Abstract][Full Text] [Related]
9. Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.
Liu B; Zhai J; Wang W; Liu T; Liu C; Zhu X; Wang Q; Tian W; Zhang F
Front Mol Biosci; 2022; 9():872932. PubMed ID: 35517856
[No Abstract] [Full Text] [Related]
10. DNA methylation regulator-based signature for predicting clear cell renal cell carcinoma prognosis.
Gong W; Yang R; Wang Z
Am J Transl Res; 2023; 15(4):2443-2459. PubMed ID: 37193150
[TBL] [Abstract][Full Text] [Related]
11. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Guo W; Zhu L; Yu M; Zhu R; Chen Q; Wang Q
Clin Epigenetics; 2018 Nov; 10(1):142. PubMed ID: 30446011
[TBL] [Abstract][Full Text] [Related]
12. From tobacco smoking to cancer mutational signature: a mediation analysis strategy to explore the role of epigenetic changes.
Chen Z; Wen W; Cai Q; Long J; Wang Y; Lin W; Shu XO; Zheng W; Guo X
BMC Cancer; 2020 Sep; 20(1):880. PubMed ID: 32928150
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer.
Li B; Jiang C; Xu Y; Fan X; Yang L; Zou B; Fan B; Wang L
BMC Cancer; 2022 Jul; 22(1):828. PubMed ID: 35906610
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Peng Q; Zhou Y; Jin L; Cao C; Gao C; Zhou J; Yang D; Zhu J
Transl Androl Urol; 2020 Jun; 9(3):1082-1098. PubMed ID: 32676392
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
Wang R; Zhu H; Yang M; Zhu C
Oncol Lett; 2019 Dec; 18(6):5831-5842. PubMed ID: 31788056
[TBL] [Abstract][Full Text] [Related]
16. Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
Zhang H; Song G; Song G; Li R; Gao M; Ye L; Zhang C
PLoS One; 2018; 13(6):e0199689. PubMed ID: 29933410
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
18. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
19. A prognostic 11-DNA methylation signature for lung squamous cell carcinoma.
Zhang J; Luo L; Dong J; Liu M; Zhai D; Huang D; Ling L; Jia X; Luo K; Zheng G
J Thorac Dis; 2020 May; 12(5):2569-2582. PubMed ID: 32642165
[TBL] [Abstract][Full Text] [Related]
20.
Kong Z; Lin Y; Jiang C; Li L; Liu Z; Wang Y; Dai C; Liu D; Qin X; Wang Y; Liu Z; Cheng X; Tian J; Ma W
Cancer Imaging; 2019 Aug; 19(1):58. PubMed ID: 31426864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
